- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PBF-509_80 mg
Total 12216 results
-
Palobiofarma SLNovartis; H. Lee Moffitt Cancer Center and Research InstituteCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Palobiofarma SLFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauTerminated
-
Fundació Institut de Recerca de l'Hospital de la...Palo Biofarma, S.LCompleted
-
PfizerCompleted
-
BioprojetCompletedParkinson's Disease | Excessive Daytime SleepinessFrance
-
Ridgeback Biotherapeutics, LPMerck Sharp & Dohme LLCCompletedSARS-CoV-2 Infection, COVID-19United States
-
PfizerCompletedAlzheimer's DiseaseKorea, Republic of, Canada, United States, Australia, United Kingdom, Belgium
-
PfizerWithdrawnUlcerative ColitisUnited States
-
PfizerTerminatedMultiple SclerosisUnited States
-
PfizerCompleted
-
PfizerCompletedAlzheimer's DiseaseUnited States
-
Medibiofarma S.L.CompletedSafety and PharmacokineticSpain
-
PfizerCompletedDiabetes Melliuts, Type 2United States
-
PfizerTerminatedParkinson's Disease With Motor FluctuationsUnited States
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Colombia, Spain, Germany, Sweden, Italy
-
9 Meters Biopharma, Inc.TerminatedShort Bowel SyndromeUnited States
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
PfizerCompletedObesity | OverweightUnited States
-
PfizerCompletedHealthy VolunteerNetherlands
-
Yale UniversityNational Institute of Mental Health (NIMH); University of Pennsylvania; Columbia... and other collaboratorsRecruitingEarly Course Schizophrenia Spectrum DisorderUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerTerminatedParkinson DiseaseUnited States, Spain, Canada, France, Japan, Germany
-
PfizerCompleted
-
PfizerCompletedHepatic Impairment | Healthy ParticipantsUnited States
-
PfizerCompleted
-
PfizerTerminated
-
PfizerCompletedHealthy ParticipantsBelgium
-
PfizerCompletedHealthy | Diabetes Mellitus, Type 2 | Renal ImpairmentUnited States
-
GlaxoSmithKlineCompleted
-
PfizerCompletedAlzheimer's DiseaseSweden
-
PfizerCompletedSystemic Lupus ErythematosusSpain, United States, Taiwan, Belgium, Czechia, Japan, Hungary, Germany, United Kingdom, China, France, Australia, Bulgaria, Hong Kong, Korea, Republic of, Colombia, Argentina, Canada, Greece, Italy, Mexico, Poland, Portugal, Romania, S... and more
-
PfizerTerminatedType 2 Diabetes Mellitus (T2DM)United States
-
PfizerWithdrawnDementia | Alzheimer's Disease | Dimebon | Investigational Drug
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
-
PfizerTerminatedHuntington's DiseaseUnited States, Germany, Poland, United Kingdom, Canada
-
Palobiofarma SLVall d'Hebron institute of oncology (VHIO), Catalan institute of oncology...Completed
-
Institute of Tropical Medicine, BelgiumWorld Bank; Ministry of Health, Burundi; Institut de Statistiques, Burundi (ISTEEBU) and other collaboratorsCompleted